Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove

Assessing Serum Neutralization Against SARS-CoV-2 with Pseudotyped Viruses

November 21st, 2023
*1, *1, 1, 1, 1, 1, 1, 2, 2, 3, 3, 1, 1
1Department of Neuroscience, Biomedicine and Movement, University of Verona, 2Laboratory of Molecular Neurovirology, Faculty of Health Science, University of Brasília, 3Viral Pseudotype Unit, Medway School of Pharmacy, Universities of Kent and Greenwich at Medway
* These authors contributed equally

Summary
Automatic Translation

Pseudotyped viruses (PVs) are replication-defective virions that are used to study host-virus interactions under safer conditions than handling authentic viruses. Presented here is a detailed protocol that shows how SARS-CoV-2 PVs can be used to test the neutralizing ability of patients' serum after COVID-19 vaccination.

Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter